{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:44:21Z","timestamp":1791902661343,"version":"4.3.4"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,25]]},"abstract":"<jats:p>This retrospective study presents 139 consecutive patients who received ritlecitinib 50\u2005mg daily in 1 UK tertiary centre. Our real-world data demonstrate that ritlecitinib is effective and well tolerated in a large UK tertiary alopecia areata cohort. The data support the observation that a\u00a0shorter disease episode duration was a significant predictor of Janus kinase inhibitor treatment response.<\/jats:p>","DOI":"10.1093\/ced\/llag067","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:30:58Z","timestamp":1770726658000},"page":"1301-1303","source":"Crossref","is-referenced-by-count":5,"title":["Ritlecitinib for the treatment of severe alopecia areata: real-world experience from a UK tertiary centre"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2775-8192","authenticated-orcid":false,"given":"Neenu","family":"Sebastian","sequence":"first","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester and NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7819-3734","authenticated-orcid":false,"given":"Azmeralda","family":"Abraheem","sequence":"additional","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester and NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-7634","authenticated-orcid":false,"given":"Anne","family":"Chandidzura","sequence":"additional","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester and NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6358-5074","authenticated-orcid":false,"given":"Heba","family":"Amsha","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Biology, Medicine and Health, University of Manchester , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jamil","sequence":"additional","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester and NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuala","family":"O\u2019Donoghue","sequence":"additional","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-8690","authenticated-orcid":false,"given":"Matthew","family":"Harries","sequence":"additional","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester and NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026062510015312100_llag067-B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"187","author":"Macbeth","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026062510015312100_llag067-B2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jvc2.495","article-title":"Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia","volume":"4","author":"Frewen","year":"2024","journal-title":"JEADV Clin Pract"},{"key":"2026062510015312100_llag067-B3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British Association of Dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026062510015312100_llag067-B4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b\u20133 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"key":"2026062510015312100_llag067-B5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jdv.20526","article-title":"Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: results from the ALLEGRO-LT phase 3, open-label study","volume":"39","author":"Tziotzios","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062510015312100_llag067-B6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/bjd\/ljae365","article-title":"Efficacy and safety of the oral Janus kinase 3\/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24\u2005months: integrated analysis of the ALLEGRO phase IIb\/III and long-term phase III clinical studies in alopecia areata","volume":"192","author":"Piliang","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026062510015312100_llag067-B7","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17829","article-title":"Long-term real-world outcomes of baricitinib in severe alopecia areata: a 104-week retrospective analysis from a single institute","author":"Wada-Irimada","year":"2025","journal-title":"J Dermatol"},{"key":"2026062510015312100_llag067-B8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/ced\/llaf055","article-title":"The Global Register of Alopecia areata disease Severity and treatment Safety \u2013 United Kingdom (GRASS-UK): importance of real-world data in alopecia areata","volume":"50","author":"Harries","year":"2025","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag067\/66853754\/llag067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/7\/1301\/66853754\/llag067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/7\/1301\/66853754\/llag067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:02:01Z","timestamp":1782396121000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/7\/1301\/8472951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":8,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,11]]},"published-print":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llag067","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,11]]}}}